Page 2 - Micelle Technology News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Key Highlights: · MGC Pharma has received a wholesale purchase order of ~€640,000 (~A$1,000,000) from leading European nutraceuticals producer and distributor, Swiss PharmaCan AG (SPC), for ArtemiCTM Rescue. · This is the second major wholesale order received by the Company for ArtemiCTM Rescue under the exclusive Master Agreement with SPC signed in February 2021. · The Company has manufacturing capacity at its production facility in Slovenia to produce commercial scale batches of ArtemiCTM Rescue as a food supplement for distribution by SPC. · Strong sales pipeline continues to deliver...

Glow LifeTech Corp.: Glow LifeTech Announces Successful First Commercial Production of ArtemiC for Global Distributor and a Second Production Scaled to Meet Growing Global Demand Glow" or the " Company"), a biotech company focused on producing next-generation, science-backed natural ingredients, is pleased to announce the successful delivery of the first commercial production run of ArtemiC at its supply partner, Swiss PharmaCan AG ("SPC") in April 2021 1, and a second production run worth nearly $1 million 2 CAD that is scaled to service the growing demand around the world. Glow ArtemiC htt...

MGC Pharmaceuticals Ltd TM Rescue · Minimum three (3) year exclusive worldwide 1 supply and distribution agreement signed with leading European nutraceuticals producer and distributor, Swiss PharmaCan AG, for the distribution of ArtemiC™ Rescue as a food supplement · This agreement follows the completion of a successful phase II double-blind, placebo-controlled clinical trial on 50 COVID-19 patients across Israel and India that met all its primary and secondary endpoints · Agreement includes minimum wholesale order quantity to MGC Pharma...

Relay Medical Corp.: Relay Medical Reports Glow LifeTech Secures Exclusive North American Rights to ArtemiC Following Successful COVID-19 Phase II Clinical Trial Relay" or the " Company"), a technology developer and innovator, and Glow LifeTech Ltd. (" Glow"), a private company in which Relay holds a significant equity interest, are pleased to report that Glow has executed an agreement with Swiss Pharmacan AG ("the agreement") for exclusive North American and Carribean sales and distribution rights for ArtemiC , a natural health product based on Glow's MyCell Technology ("MyCell") which recen...

(2) Glow LifeTech has the exclusive rights for MyCell Technology in the United States, Canada and Mexico for one of the primary ingredients used in ArtemiC, a COVID-19 Treatment Candidate with successful Phase II Clinical Results The formulation statistically significantly improved the clinical recovery of COVID-19 patients in the treatment group in comparison with placebo and 100% of the patients in the treatment group fully recovered within 15 days Positive results from a phase II double blind randomized controlled clinical trial show the MyCell Technology ArtemiC formulation, successfully ...